TYK40: Difference between revisions
Jump to navigation
Jump to search
m (1 revision imported) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
In the infant population, which of the following NMBA is an intermediate acting agent? | In the infant population, which of the following NMBA is an intermediate acting agent? | ||
| Line 10: | Line 9: | ||
D. Pancuronium | D. Pancuronium | ||
<div class="mw-customtoggle-TYK_Answer" style="text-align: right; color:#0000ff">Click for Answer</div> | |||
<div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-TYK_Answer"> | |||
<div class="mw-collapsible- | |||
==Answer== | ==Answer== | ||
The answer is A. Pancuronium is a long acting agent (>50 mins) in any population. While in adults and children rocuronium and vecuronium are intermediate acting agents (20-50 mins), in the infant population these agents have a consistently prolonged duration of action (making them long acting agents in this population). This is due to a longer residence time and a lower site concentration needed for effect (increased sensitivity) in the infant. | The answer is A. Pancuronium is a long acting agent (>50 mins) in any population. While in adults and children rocuronium and vecuronium are intermediate acting agents (20-50 mins), in the infant population these agents have a consistently prolonged duration of action (making them long acting agents in this population). This is due to a longer residence time and a lower site concentration needed for effect (increased sensitivity) in the infant. | ||
==Notes== | ==Notes== | ||
<references /> | <references /> | ||
==Keywords== | ==Keywords== | ||
</div> | </div> | ||
---- | ---- | ||
---- | ---- | ||
Latest revision as of 22:24, 23 January 2022
In the infant population, which of the following NMBA is an intermediate acting agent?
A. Atracurium
B. Rocuronium
C. Vecuronium
D. Pancuronium
Click for Answer
Answer
The answer is A. Pancuronium is a long acting agent (>50 mins) in any population. While in adults and children rocuronium and vecuronium are intermediate acting agents (20-50 mins), in the infant population these agents have a consistently prolonged duration of action (making them long acting agents in this population). This is due to a longer residence time and a lower site concentration needed for effect (increased sensitivity) in the infant.
Notes